Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. (Q45964186)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. |
scientific article |
Statements
1 reference
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. (English)
1 reference
1 reference
Jeffrey S Weber
1 reference
Hassan Zarour
1 reference
Bruce Redman
1 reference
Uwe Trefzer
1 reference
Steven O'Day
1 reference
Alfons J M van den Eertwegh
1 reference
Ernest Marshall
1 reference
1 September 2009
1 reference
1 reference
115
1 reference
17
1 reference
3944-3954
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference